Skip to main content
. Author manuscript; available in PMC: 2011 Sep 1.
Published in final edited form as: Liver Transpl. 2010 Sep;16(9):1041–1048. doi: 10.1002/lt.22120

Table 5. Univariate Analysis of Risk Factors for Currently Receiving Special Education Services, Factors p ≤ 0.10.

Factor Comparison Group Reference Group Odds
Ratio
p-value
Primary diagnosis Other Cholestatic or
Metabolic
Fulminant liver failure
Cirrhosis
Other
Biliary atresia 1.54
1.01
0.63
1.27
p = 0.0448
Growth Deficit at
Tx
Yes No 1.39 p = 0.0477
Immunosuppressio
n at Tx
Cyclosporine
Other
Tacrolimus 1.72
0.63
p = 0.0057
Immuno at 6
months post tx
Cyclosporine
Other
Tacrolimus 1.59
5.49
p = 0.0019
Nutrition Intake at
Listing
Tube
IV
Mouth 1.75
1.38
p = 0.0289
Early use of
monoclonal or
polyclonal
antibodies
Yes No 1.41 p = 0.0846
Symptomatic
CMV within 6
mths of Tx
Yes No 2.15 p = 0.0051
PreTx Special Edu
Needs
Yes No 13.97 p <0.0001
Parent Highest
Edu
College or Above Less than College 0.70 p = 0.0234
Year of Tx >=2002 <=2001 0.72 p = 0.0354
Initial Hospital
Stay
Continuous Predictor 1.01 p = 0.0008
Log INR Continuous Predictor 0.75 p = 0.0985
Change in weight
z score at 6 months
post Tx
Continuous Predictor 0.87 p = 0.0600